Connect Sign In
Utah Business magazine has honored ARUP Laboratories with a 2023 Best Companies to Work For Award. ARUP has earned this award every year since 2018. |
December 1, 2023 |
ARUP Laboratories Honored With 2023 Best Companies to Work For Award From Utah Business Magazine Utah Business magazine honored ARUP Laboratories with its Best Companies to Work For award for the sixth consecutive year based on anonymous employee survey results. |
ARUP Laboratories has released the company’s public comment in response to the FDA’s plan to regulate LDTs. |
November 29, 2023 |
ARUP Laboratories Urges FDA to Withdraw Proposed Rule Regulating Laboratory-Developed Tests ARUP believes the FDA’s plan to regulate lab-developed tests will limit access to testing, increase costs, and face a court challenge, and is calling for collaboration to better address LDT oversight. |
AAV5 DetectCDx™ detects the presence of anti-AAV5 antibodies to aid in the selection of patients eligible for the treatment ROCTAVIAN™. |
November 10, 2023 |
EU Approval of AAV5 DetectCDx™ Provides Access to Companion Diagnostic for Hemophilia A Gene Therapy ARUP has gained a Conformité Européenne (CE) mark for AAV5 DetectCDx™ single-site use. The test will aid in determining the eligibility of non-U.S. patients for a new hemophilia A gene therapy. |
Dave Shiembob, manager of ARUP Healthcare Advisory Services, guides clients with utilization best practices and real-time opportunities. |
October 10, 2023 |
ARUP Healthcare Advisory Services Wins a Third ASCP Choosing Wisely Champion Award A platform clients use to reduce testing waste, lower cost per test, and improve patient safety has won the prestigious Choosing Wisely Champion Award from the American Society for Clinical Pathology. |
Founding members of the new Institute for Research and Innovation in Diagnostic and Precision MedicineTM gather. In the back row, from left to right, are David P. Ng, MD; Hunter Best, PhD, FACMG; Tracy George, MD; Leo Lin, MD, PhD; and Brendan O’Fallon. In the front row, from left to right, are Salika M. Shakir, PhD, D(ABMM); Robert S. Ohgami, MD, PhD, FCAP; Benjamin Bradley, MD, PhD; and Erica Clyde. Not pictured: Tatiana Yuzyuk, PhD, ABMGG; Evan Raps, MD; Peng Li, MD, PhD; and Valarie McMurtry, MD, PhD. |
September 29, 2023 |
ARUP’s New Institute for Research and Innovation in Diagnostic and Precision Medicine™ New ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ will improve patient lives by advancing groundbreaking diagnostic and prognostic technologies. |
ARUP Blood Services has aligned its donor eligibility assessment processes to follow recent U.S. Food and Drug Administration (FDA) guideline updates, and the changes will take effect on July 18, 2023. |
July 5, 2023 |
ARUP Blood Services Implements Changes in Response to New FDA Guidelines on Blood Donor The FDA now recommends the same assessment questions for all donors, regardless of gender or sexual orientation. ARUP Blood Services is one of the first donor centers to update processes in response. |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ We accelerate the development and adoption of cutting-edge diagnostic and prognostic technologies advancing patient care through groundbreaking science and engineering. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
Press Releases
Live Chat